FBIO Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.

$3.07  -0.09 (-2.70%)
As of 07/23/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/19/2011
Outstanding shares:  97,319,238
Average volume:  442,482
Market cap:   $306,555,600
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    34960Q109
ISIN:        US34960Q1094
Sedol:      BWT3FG4
Valuation   (See tab for details)
PE ratio:   -6.93
PB ratio:   2.81
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy